Viridian Therapeutics, Inc.\DE (VRDN) Price to Sales (2014 - 2026)
Viridian Therapeutics, Inc.\DE's (VRDN) Price to Sales stood at 29.25 in Q2 2026, down 99.2% from 3742.57 a year earlier but up 3.5% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Price to Sales (2014 - 2026) Analysis & Trends
For FY2025, Viridian Therapeutics, Inc.\DE's Price to Sales came in at 37.25, down 99.3% from FY2024.
- Across earlier years, Price to Sales came in at 5141.24 in FY2024 (+65.6%), 3104.38 in FY2023 (+486.9%), 528.93 in FY2022 (+565.1%) and 79.53 in FY2021 (+20.0%).
- Quarterly Price to Sales has ranged from 25.07 in Q3 2025 to 5964.83 in Q3 2024 over the past five years.
- On a year-over-year basis, Price to Sales has declined for four consecutive quarters, with an average decline of 12.4% over the last eight quarters.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 568.6% in Q3 2022, against a decline of 99.6% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 28.26 (Q1 2026), 37.25 (Q4 2025) and 25.07 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.25 |
| Mar 31, 2026 | 28.26 |
| Dec 31, 2025 | 37.25 |
| Sep 30, 2025 | 25.07 |
| Jun 30, 2025 | 3,742.57 |
| Mar 31, 2025 | 3,641.81 |
| Dec 31, 2024 | 5,141.24 |
| Sep 30, 2024 | 5,964.83 |
| Jun 30, 2024 | 2,885.68 |
| Mar 31, 2024 | 3,878.86 |
| Dec 31, 2023 | 3,104.38 |
| Sep 30, 2023 | 1,931.91 |
| Jun 30, 2023 | 705.00 |
| Mar 31, 2023 | 662.23 |
| Dec 31, 2022 | 528.93 |
| Sep 30, 2022 | 438.82 |
| Jun 30, 2022 | 368.38 |
| Mar 31, 2022 | 255.99 |
| Dec 31, 2021 | 79.53 |
| Sep 30, 2021 | 65.63 |
API Access
Viridian Therapeutics, Inc.\DE Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();